137 related articles for article (PubMed ID: 37364502)
41. ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis.
Kondo T; Takeuchi K; Doi Y; Yonemura S; Nagata S; Tsukita S
J Cell Biol; 1997 Nov; 139(3):749-58. PubMed ID: 9348291
[TBL] [Abstract][Full Text] [Related]
42. Ezrin, Radixin and Moesin: key regulators of membrane-cortex interactions and signaling.
Neisch AL; Fehon RG
Curr Opin Cell Biol; 2011 Aug; 23(4):377-82. PubMed ID: 21592758
[TBL] [Abstract][Full Text] [Related]
43. Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin.
Kawaguchi K; Asano S
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328667
[TBL] [Abstract][Full Text] [Related]
44. Ezrin/radixin/moesin proteins differentially regulate endothelial hyperpermeability after thrombin.
Adyshev DM; Dudek SM; Moldobaeva N; Kim KM; Ma SF; Kasa A; Garcia JG; Verin AD
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(3):L240-55. PubMed ID: 23729486
[TBL] [Abstract][Full Text] [Related]
45. Decreased radixin function for ATP-binding cassette transporters in liver in adjuvant-induced arthritis rats.
Kawase A; Sakata M; Yada N; Nakasaka M; Shimizu T; Kato Y; Iwaki M
J Pharm Sci; 2014 Dec; 103(12):4058-4065. PubMed ID: 25331966
[TBL] [Abstract][Full Text] [Related]
46. Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment.
Wang R; Zhang C; Cao Y; Wang J; Jiao S; Zhang J; Wang M; Tang P; Ouyang Z; Liang W; Mao Y; Wang A; Li G; Zhang J; Wang M; Wang S; Gui X
Theranostics; 2023; 13(1):148-160. PubMed ID: 36593962
[No Abstract] [Full Text] [Related]
47. Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.
Narla RK; Modi H; Bauer D; Abbasian M; Leisten J; Piccotti JR; Kopytek S; Eckelman BP; Deveraux Q; Timmer J; Zhu D; Wong L; Escoubet L; Raymon HK; Hariharan K
Cancer Immunol Immunother; 2022 Feb; 71(2):473-489. PubMed ID: 34247273
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.
Chao MP; Takimoto CH; Feng DD; McKenna K; Gip P; Liu J; Volkmer JP; Weissman IL; Majeti R
Front Oncol; 2019; 9():1380. PubMed ID: 32038992
[TBL] [Abstract][Full Text] [Related]
49. Sphingosine 1-phosphate-mediated activation of ezrin-radixin-moesin proteins contributes to cytoskeletal remodeling and changes of membrane properties in epithelial otic vesicle progenitors.
Cencetti F; Bernacchioni C; Bruno M; Squecco R; Idrizaj E; Berbeglia M; Bruni P; Donati C
Biochim Biophys Acta Mol Cell Res; 2019 Apr; 1866(4):554-565. PubMed ID: 30611767
[TBL] [Abstract][Full Text] [Related]
50. Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo.
Yonemura S; Matsui T; Tsukita S; Tsukita S
J Cell Sci; 2002 Jun; 115(Pt 12):2569-80. PubMed ID: 12045227
[TBL] [Abstract][Full Text] [Related]
51. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
[TBL] [Abstract][Full Text] [Related]
52. Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K
Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
[TBL] [Abstract][Full Text] [Related]
53. ERM Proteins Play Distinct Roles in Cell Invasion by Extracellular Amastigotes of
Ferreira ÉR; Bonfim-Melo A; Cordero EM; Mortara RA
Front Microbiol; 2017; 8():2230. PubMed ID: 29209287
[TBL] [Abstract][Full Text] [Related]
54. Normal development of mice and unimpaired cell adhesion/cell motility/actin-based cytoskeleton without compensatory up-regulation of ezrin or radixin in moesin gene knockout.
Doi Y; Itoh M; Yonemura S; Ishihara S; Takano H; Noda T; Tsukita S
J Biol Chem; 1999 Jan; 274(4):2315-21. PubMed ID: 9890997
[TBL] [Abstract][Full Text] [Related]
55. CD47 as a promising therapeutic target in oncology.
Zhao H; Song S; Ma J; Yan Z; Xie H; Feng Y; Che S
Front Immunol; 2022; 13():757480. PubMed ID: 36081498
[TBL] [Abstract][Full Text] [Related]
56. Disruption of dynamic cell surface architecture of NIH3T3 fibroblasts by the N-terminal domains of moesin and ezrin: in vivo imaging with GFP fusion proteins.
Amieva MR; Litman P; Huang L; Ichimaru E; Furthmayr H
J Cell Sci; 1999 Jan; 112 ( Pt 1)():111-25. PubMed ID: 9841908
[TBL] [Abstract][Full Text] [Related]
57. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.
Chen SH; Dominik PK; Stanfield J; Ding S; Yang W; Kurd N; Llewellyn R; Heyen J; Wang C; Melton Z; Van Blarcom T; Lindquist KC; Chaparro-Riggers J; Salek-Ardakani S
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599020
[TBL] [Abstract][Full Text] [Related]
58. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members.
Takeuchi K; Sato N; Kasahara H; Funayama N; Nagafuchi A; Yonemura S; Tsukita S; Tsukita S
J Cell Biol; 1994 Jun; 125(6):1371-84. PubMed ID: 8207064
[TBL] [Abstract][Full Text] [Related]
59. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
[TBL] [Abstract][Full Text] [Related]
60. EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins.
Sala-Valdés M; Ursa A; Charrin S; Rubinstein E; Hemler ME; Sánchez-Madrid F; Yáñez-Mó M
J Biol Chem; 2006 Jul; 281(28):19665-75. PubMed ID: 16690612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
